BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 28665491)

  • 1. Feasibility of dynamic adaptive passive scattering proton therapy with computed tomography image guidance in the lung.
    Moriya S; Tachibana H; Hotta K; Nakamura N; Sakae T; Akimoto T
    Med Phys; 2017 Sep; 44(9):4474-4481. PubMed ID: 28665491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
    Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
    Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.
    Liu W; Schild SE; Chang JY; Liao Z; Chang YH; Wen Z; Shen J; Stoker JB; Ding X; Hu Y; Sahoo N; Herman MG; Vargas C; Keole S; Wong W; Bues M
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):523-533. PubMed ID: 26725727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Range optimization for target and organs at risk in dynamic adaptive passive scattering proton beam therapy - A proof of concept.
    Moriya S; Tachibana H; Hotta K; Nakamura N; Sakae T; Akimoto T
    Phys Med; 2018 Dec; 56():66-73. PubMed ID: 30527091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer.
    Shan J; Yang Y; Schild SE; Daniels TB; Wong WW; Fatyga M; Bues M; Sio TT; Liu W
    Med Phys; 2020 Nov; 47(11):5428-5440. PubMed ID: 32964474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapy.
    Li X; Kabolizadeh P; Yan D; Qin A; Zhou J; Hong Y; Guerrero T; Grills I; Stevens C; Ding X
    Radiat Oncol; 2018 Feb; 13(1):35. PubMed ID: 29486782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating CT to CBCT image registration for head and neck proton therapy as a tool for daily dose recalculation.
    Landry G; Nijhuis R; Dedes G; Handrack J; Thieke C; Janssens G; Orban de Xivry J; Reiner M; Kamp F; Wilkens JJ; Paganelli C; Riboldi M; Baroni G; Ganswindt U; Belka C; Parodi K
    Med Phys; 2015 Mar; 42(3):1354-66. PubMed ID: 25735290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing 3DCT image registration for interfractional changes in carbon-ion prostate radiotherapy.
    Hirai R; Mori S; Suyari H; Tsuji H; Ishikawa H
    Sci Rep; 2023 May; 13(1):7448. PubMed ID: 37156901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
    Rana S; Greco K; Samuel EJJ; Bennouna J
    J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
    Rana S; Zheng Y
    J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of adaptive treatment planning for patients with non-small cell lung cancer.
    Zhong H; Siddiqui SM; Movsas B; Chetty IJ
    Phys Med Biol; 2017 Jun; 62(11):4346-4360. PubMed ID: 28072395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Real-Time Image Gating on Spot Scanning Proton Therapy for Lung Tumors: A Simulation Study.
    Kanehira T; Matsuura T; Takao S; Matsuzaki Y; Fujii Y; Fujii T; Ito YM; Miyamoto N; Inoue T; Katoh N; Shimizu S; Umegaki K; Shirato H
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):173-181. PubMed ID: 27856039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
    Seco J; Gu G; Marcelos T; Kooy H; Willers H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the anatomic changes and dosimetric consequences in adaptive CRT of non-small-cell lung cancer using deformable CT and CBCT image registration.
    Ma C; Hou Y; Li H; Li D; Zhang Y; Chen S; Yin Y
    Technol Cancer Res Treat; 2014 Apr; 13(2):95-100. PubMed ID: 23919391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study.
    Liu C; Sio TT; Deng W; Shan J; Daniels TB; Rule WG; Lara PR; Korte SM; Shen J; Ding X; Schild SE; Bues M; Liu W
    J Appl Clin Med Phys; 2018 Nov; 19(6):140-148. PubMed ID: 30328674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is an analytical dose engine sufficient for intensity modulated proton therapy in lung cancer?
    Teoh S; Fiorini F; George B; Vallis KA; Van den Heuvel F
    Br J Radiol; 2020 Mar; 93(1107):20190583. PubMed ID: 31696729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positioning accuracy and daily dose assessment for prostate cancer treatment using in-room CT image guidance at a proton therapy facility.
    Maeda Y; Sato Y; Minami H; Yasukawa Y; Yamamoto K; Tamamura H; Shibata S; Bou S; Sasaki M; Tameshige Y; Kume K; Ooto H; Kasahara S; Shimizu Y; Saga Y; Omoya A; Saitou M
    Med Phys; 2018 May; 45(5):1832-1843. PubMed ID: 29532489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric feasibility of real-time MRI-guided proton therapy.
    Moteabbed M; Schuemann J; Paganetti H
    Med Phys; 2014 Nov; 41(11):111713. PubMed ID: 25370627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans.
    Stuschke M; Kaiser A; Pöttgen C; Lübcke W; Farr J
    Radiother Oncol; 2012 Jul; 104(1):45-51. PubMed ID: 22560714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.